AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone

Clinical trial NCT00395967 · TERMINATED

Trial details

NCT number: NCT00395967
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Lymphoma, Non-Hodgkin's

Start date: 2005-04-01
Primary completion: 2005-07-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.